Breaking News Instant updates and real-time market news.

DRI

Darden

$61.36

0.04 (0.07%)

07:14
10/04/16
10/04
07:14
10/04/16
07:14

Darden up over 5% to $64.80 after Q1 results, guidance

  • 04

    Oct

  • 02

    Nov

DRI Darden
$61.36

0.04 (0.07%)

07/13/16
WELS
07/13/16
DOWNGRADE
WELS
Market Perform
Darden downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Jeff Farmer downgraded Darden Restaurants to Market Perform citing accelerating casual dining segment same-same-store declines in June. The analyst expects a diminished rate of upward earnings revision in coming quarters. He cut his price target range for the shares to $66-$70 from $70-$74.
07/26/16
STFL
07/26/16
DOWNGRADE
STFL
Sell
Darden downgraded to Sell from Hold at Stifel
Stifel analyst Paul Westra downgraded Darden based on the firm's belief that the U.S. economy will probably enter a recession within nine months. As a result, the firm now expects two year industrywide comps to come in at 0.5% in the first half of 2018, versus the consensus outlook of 1.75%, Westra stated. The analyst says that Darden's Olve Garden and Longhorn brands are already seeing weak demand, while the company lacks "brand agility" amid "fierce competition." Target $53.
08/22/16
ADAM
08/22/16
INITIATION
Target $74
ADAM
Buy
Darden initiated with a Buy at Canaccord
Canaccord analyst Lynne Collier initiated coverage on the Restaurant industry with an overall cautious outlook, saying that being selective is key. The analyst started coverage of Darden with a Buy rating and $74 price target, making it one of only four Buy rated stocks among fifteen that were initiated.
09/06/16
OPCO
09/06/16
NO CHANGE
Target $70
OPCO
Outperform
Darden at a 'misplaced discount' to peers, says Oppenheimer
Oppenheimer analyst Brian Bittner believes the market has presented another Darden buying opportunity, with stock valuation sitting at a "misplaced discount" to peers. Further, the analyst believes better in-store execution, improved off-premise business and elevated brand momentum can sustain sales trends above peers. Bittner also sees limited risk to upcoming Q1 results. He reiterates an Outperform rating and $70 price target on the shares.

TODAY'S FREE FLY STORIES

CR

Crane

$77.91

1.37 (1.79%)

17:02
04/24/17
04/24
17:02
04/24/17
17:02
Earnings
Crane reports Q1 EPS $1.05, consensus $1.00 »

Reports Q1 revenue $673M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 09

    May

MRK

Merck

$62.14

0.25 (0.40%)

, BIIB

Biogen

$276.86

3.92 (1.44%)

17:02
04/24/17
04/24
17:02
04/24/17
17:02
Hot Stocks
FDA clears Remicade biosimilar from Samsung Bioepis »

The FDA has granted…

MRK

Merck

$62.14

0.25 (0.40%)

BIIB

Biogen

$276.86

3.92 (1.44%)

JNJ

Johnson & Johnson

$122.89

1.13 (0.93%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 02

    May

  • 03

    May

  • 07

    May

  • 10

    May

  • 27

    May

  • 31

    May

  • 06

    Jun

  • 09

    Jun

  • 14

    Jun

AMP

Ameriprise

$131.86

3.42 (2.66%)

17:01
04/24/17
04/24
17:01
04/24/17
17:01
Hot Stocks
Breaking Hot Stocks news story on Ameriprise »

Ameriprise announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

AMP

Ameriprise

$131.86

3.42 (2.66%)

17:01
04/24/17
04/24
17:01
04/24/17
17:01
Hot Stocks
Breaking Hot Stocks news story on Ameriprise »

Ameriprise raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

AKRX

Akorn

$32.72

-0.19 (-0.58%)

, FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

17:00
04/24/17
04/24
17:00
04/24/17
17:00
Hot Stocks
Akorn backs FY17 adjusted EPS view $1.53-$1.72, consensus $1.63 »

Backs FY17 revenue view…

AKRX

Akorn

$32.72

-0.19 (-0.58%)

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMP

Ameriprise

$131.86

3.42 (2.66%)

17:00
04/24/17
04/24
17:00
04/24/17
17:00
Earnings
Ameriprise reports Q1 operating EPS $2.70, consensus $2.52 »

Reports Q1 revenue $2.9B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

SMMF

Summit Financial Group

$23.00

0.28 (1.23%)

17:00
04/24/17
04/24
17:00
04/24/17
17:00
Hot Stocks
Breaking Hot Stocks news story on Summit Financial Group »

Summit Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

, AKRX

Akorn

$32.72

-0.19 (-0.58%)

16:59
04/24/17
04/24
16:59
04/24/17
16:59
Hot Stocks
Fresenius to acquire Akorn for $34 per share »

Fresenius Kabi (FSNUY)…

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

AKRX

Akorn

$32.72

-0.19 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

, AKRX

Akorn

$32.72

-0.19 (-0.58%)

16:58
04/24/17
04/24
16:58
04/24/17
16:58
Hot Stocks
Breaking Hot Stocks news story on Fresenius SE, Akorn »

Fresenius to acquire…

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

AKRX

Akorn

$32.72

-0.19 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

, AKRX

Akorn

$32.72

-0.19 (-0.58%)

16:58
04/24/17
04/24
16:58
04/24/17
16:58
Periodicals
Breaking Periodicals news story on Fresenius SE, Akorn »

Fresenius SE to acquire…

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

AKRX

Akorn

$32.72

-0.19 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$53.65

0.65 (1.23%)

16:56
04/24/17
04/24
16:56
04/24/17
16:56
Hot Stocks
Wells Fargo: 'Pleased' with Fed, FDIC findings, committed to 'sound resolution' »

Wells Fargo issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

OMED

OncoMed

$3.77

0.04 (1.07%)

16:48
04/24/17
04/24
16:48
04/24/17
16:48
Hot Stocks
OncoMed announces workforce reduction »

OncoMed Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ESRX

Express Scripts

$67.25

0.79 (1.19%)

, ANTM

Anthem

$168.41

0.61 (0.36%)

16:46
04/24/17
04/24
16:46
04/24/17
16:46
Hot Stocks
Express Scripts down 12% after contract with Anthem unlikely to be renewed »

In after hours trading,…

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 18

    May

  • 06

    Jun

OI

Owens-Illinois

$21.34

0.83 (4.05%)

16:46
04/24/17
04/24
16:46
04/24/17
16:46
Earnings
Owens-Illinois sees FY17 EPS $2.40-$2.50, consensus $2.43 »

The Company continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ESRX

Express Scripts

$67.25

0.79 (1.19%)

16:45
04/24/17
04/24
16:45
04/24/17
16:45
Hot Stocks
Breaking Hot Stocks news story on Express Scripts »

Express Scripts trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 06

    Jun

OI

Owens-Illinois

$21.34

0.83 (4.05%)

16:44
04/24/17
04/24
16:44
04/24/17
16:44
Earnings
Owens-Illinois reports Q1 EPS 58c, consensus 53c »

Reports Q1 revenue $1.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

WFC

Wells Fargo

$53.65

0.65 (1.23%)

16:44
04/24/17
04/24
16:44
04/24/17
16:44
Hot Stocks
Federal Reserve, FDIC approve revised Wells Fargo living will »

The Federal Deposit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

ESRX

Express Scripts

$67.25

0.79 (1.19%)

, ANTM

Anthem

$168.41

0.61 (0.36%)

16:43
04/24/17
04/24
16:43
04/24/17
16:43
Hot Stocks
Express Scripts CEO: 'Perplexed' by potential loss of Anthem contract »

Says Anthem deal is…

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 18

    May

  • 06

    Jun

SMMF

Summit Financial Group

$23.00

0.28 (1.23%)

16:41
04/24/17
04/24
16:41
04/24/17
16:41
Hot Stocks
Summit Financial Group announces resolution of litigation »

Summit Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$80.05

0.77 (0.97%)

, ESRX

Express Scripts

$67.25

0.79 (1.19%)

16:39
04/24/17
04/24
16:39
04/24/17
16:39
Hot Stocks
Breaking Hot Stocks news story on CVS Health, Express Scripts, Anthem »

CVS up 2% after Express…

CVS

CVS Health

$80.05

0.77 (0.97%)

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 02

    May

  • 10

    May

  • 18

    May

  • 06

    Jun

NVS

Novartis

$74.61

1.21 (1.65%)

16:39
04/24/17
04/24
16:39
04/24/17
16:39
Hot Stocks
Novartis expands pact with Amgen to commercialize AMG 334 for migraine »

Novartis (NVS) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 06

    Jun

  • 26

    Jun

HMN

Horace Mann

$39.25

0.15 (0.38%)

16:39
04/24/17
04/24
16:39
04/24/17
16:39
Earnings
Horace Mann reports Q1 EPS 37c with items, may not compare to consensus 55c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

WNC

Wabash

$20.36

0.64 (3.25%)

16:36
04/24/17
04/24
16:36
04/24/17
16:36
Earnings
Breaking Earnings news story on Wabash »

Wabash sees FY17 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 23

    May

  • 24

    May

WFC

Wells Fargo

$53.65

0.65 (1.23%)

16:36
04/24/17
04/24
16:36
04/24/17
16:36
Periodicals
Breaking Periodicals news story on Wells Fargo »

Fed clears Wells Fargo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

WNC

Wabash

$20.36

0.64 (3.25%)

16:35
04/24/17
04/24
16:35
04/24/17
16:35
Earnings
Wabash reports Q1 EPS 32c, consensus 27c »

Reports Q1 revenue $363M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 23

    May

  • 24

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.